Algert Global LLC Blueprint Medicines Corp Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Algert Global LLC holds 92,236 shares of BPMC stock, worth $10.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

92,236

Previous 65,540 40.73%

Holding current value

$10.3 Million

Previous $7.06 Million 20.78%

% of portfolio

0.23%

Previous 0.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$84.1 - $120.5 $2.25 Million - $3.22 Million	26,696 Added 40.73%	92,236 $8.53 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $2.5 Million - $3.19 Million	29,330 Added 81.0%	65,540 $7.06 Million
Q1 2024 May 14, 2024	BUY	$73.17 - $99.79 $898,527 - $1.23 Million	12,280 Added 51.32%	36,210 $3.44 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $789,961 - $1.67 Million	17,970 Added 301.51%	23,930 $2.21 Million
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $279,524 - $393,360	5,960 New	5,960 $299,000
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $47,491 - $73,657	1,050 Added 9.75%	11,819 $597,000
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $78,823 - $160,386	1,457 Added 15.65%	10,769 $688,000
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $602,634 - $741,640	6,394 Added 219.12%	9,312 $997,000
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $236,299 - $319,433	2,918 New	2,918 $300,000
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $718,523 - $1 Million	-10,813 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$57.09 - $79.27 $853,495 - $1.19 Million	-14,950 Reduced 58.03%	10,813 $843,000
Q1 2020 May 13, 2020	BUY	$48.11 - $82.22 $1.24 Million - $2.12 Million	25,763 New	25,763 $1.51 Million
Q4 2018 Feb 01, 2019	SELL	$45.57 - $74.26 $260,751 - $424,915	-5,722 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $337,083 - $448,147	5,722 New	5,722 $447,000

Others Institutions Holding BPMC

# of Institutions

356

Shares Held

60.7M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.66B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Blueprint Medicines Corp Transaction History